Conclusion
These findings have given us renewed hope of identifying the causes of other inborn immune defects and eventually of curing them. Continued studies may lead to development of better immunosuppressive drugs and to a deeper understanding of the influence of nucleic acid metabolism on immune function.
Similar content being viewed by others
Abbreviations
- 1. ADA:
-
Adenosine deaminase (EC 3.5.4.4)
- 2. SCID:
-
Severe combined immunodeficiency
- 3. T cell:
-
Thymus-derived lymphocyte
- 4. PNP:
-
Purine-nucleoside phosphorylase (EC 2.4.2.1)
- 5. ATP:
-
Adenosine triphosphate
- 6. Ig:
-
Immunoglobulin
- 7. B cell:
-
Bone marrow-derived lymphocyte
- 8. AMP:
-
Adenosine monophosphate
- 9. ADP:
-
Adenosine diphosphate
- 10. HLA:
-
Human leukocyte group A
- 11. MLC:
-
Mixed leukocyte culture
References
Giblett, E. R., Anderson, J. E., Cohen, F., et al.: Adenosine deaminase deficiency in two patients with severely impaired cellular immunity, LancetII, 1067 (1972)
Meuwissen, H. J., Pollara, B., Pickering, R. J., et al.: Combined immunodeficiency disease associated with ADA deficiency. J. Pediatr.86, 169 (1975)
Meuwissen, H. J., Pickering, R. J., Pollara, B., Porter, I. H. (eds.): Combined immunodeficiency disease and adenosine deaminase deficiency. A molecular defect. New York: Academic Press 1975
Yount, J., Nichols, P., Ochs, H. D., et al.: Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J. Pediatr.84, 173 (1974)
Keightley, R. G., Lawton, A. R., Cooper, M. D., et al.: Successful fetal liver transplantation in a child with severe combined immunodeficiency. Lancet2, 850 (1975)
Parkman, R., Gelfand, E. W., Rosen, F., et al.: Severe combined immunodeficiency and adenosine deaminase deficiency. New Engl. J. Med.2, 714 (1975)
Cederbaum, S. D., Kaitila, I., Rimoin, D. L., et al.: The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J. Pediatr.89, 737 (1976)
Trotta, P. P., Smithwick, E. M., Balis, M. E.: A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease. Proc. Nat. Acad. Sci. USA73, 104 (1976)
Hitzig, W. H., Landolt, R., Mueller, G. et al.: Heterogeneity of phenotypic expression in a family with Swiss-type agammaglobulinemia. Observations on the acquisition of agammaglobulinemia. J. Pediatr.78, 968 (1971)
Ackeret, C., Plüss, H. J., Hitzig, W. H.: Hereditary severe combined immunodeficiency and adenosine deaminase deficiency. Pediatr. Res.10, 67 (1976)
Mills, G., Schmalstieg, F., Trimmer, K., et al.: Purine metabolism in adenosine deaminase deficiency. Proc. Nat. Acad. Sci. USA73, 2867 (1976)
Polmar, S., Stern, R., Schwartz, A., et al.: Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. New Engl. J. Med.295, 1337 (1976)
Schmalstieg, F. C., Nelson, J. A., Mills, G., et al.: Increased purine nucleotides in adenosine deaminase-deficient lymphocytes. J. Pediatr.91, 48 (1977)
Wolf, J. W., Anderson, J. A., Reid, R. H., et al.: Syndrome of cellular immunodeficiency with immunoglobulins associated with adenosine deaminase deficiency. Ped. Res.10, 394 (1976)
Cohen, A., Hirschhorn, R., Horowitz, S. et al.: Deoxyadenosine tryphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc. Nat. Acad. Sci.75, 472 (1978)
Lum, C. T., Sutherland, D., Najarian, J.: ADA inhibition and skin graft rejection. ADA inhibition for immunosuppression. New Engl. J. Med.296, 819 (1977)
Chassin, M. M., Chirigos, M. A., Johns, D., et al.: Adenosine deaminase inhibition for immunosuppression. New Engl. J. Med.296, 1232 (1977)
Burridge, P. W., Paetkau, V., Henderson, J. F.: Studies of the relationship between adenosine deaminase and immune function. J. Immunol.119, 675 (1977)
Ballet, J. J., Insel, R., Merler, E., et al.: Inhibition of maturation of human precursor lymphocytes by Coformycin, an inhibitor of the enzyme adenosine deaminase. J. Exp. Med.143, 1271 1976)
Carson, D., Seegmiller, J.: Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J. Clin. Invest.57, 274 (1976)
Giblett, E., Amman, A., Wara, D., et al.: Nucleoside phosphorylase deficiency in a child with severe defective T-cell immunity and normal B-cell immunity. Lancet1, 1010 (1975)
Jenkins, T., Rabson, A., Nurse, G., et al.: Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J. Pediatr.89, 732 (1976)
Carter, R., Meuwissen, H. J.: Unpublished observations
Borkowsky, W., Gershorn, A., Hirschhorn, R.: Adenosine deaminase deficiency without immunodeficiency. Ped. Res.12, 478 (1978)
Hershfield, M. S., Snyder, F. F., Seegmiller, J. E.: Adenine and adenosine are toxic to human lymphoblast mutants defective in purine salvage enzymes. Science197, 1284 (1977)
Simmonds, H. A., Panayi, G. S., Corrigall, V.: A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism. Lancet1, 60 (1978)
Wolberg, G., Zimmerman, T. P., Hiemstra, K.: Adenosine inhibition of lymphocyte mediated cytolysis. Possible role of cyclic adenosine monophosphate. Science187, 957 (1975)
Carson, D., Kaye, J., Seegmiller, J.: Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(s). Proc. Nat. Acad. Sci.74, 5677 (1977)
Van Der Weyden, M., Buckley, R., Kelley, W.: Molecular form of adenosine deaminase in severe combined immunodeficiency. Biochem. Biophys. Res. Comm.57, 590 (1974)
Hirschhorn, R., Beratis, N., Rosen, F. S.: Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: Evidence for a mutant enzyme. Proc. Nat. Acad. Sci. USA73, 213 (1976)
Chen, S., Scott, C., Giblett, E.: Adenosine deaminase: Demonstration of a “silent” gene associated with combined immunodeficiency disease. Am. J. Hum. Genet.26, 103 (1974)
Hirschhorn, R.: Defects of purine metabolism in immunodeficiency disease. Prog, in Clin. Immunol.3, 67 (1977)
Hirschhorn, R., Beratis, N., Rosen, F. S., et al.: Adenosine-deaminase deficiency in a child diagnosed prenatally. Lancet1, 73 (1975)
Schmallstieg, F. C., Goldblum, R. M., Mills, G. C., et al.: Effect of RBC transfusions on adenosine deaminase (ADA) deficient severe combined immunodeficiency (SCID). Fed. Res.11, 493 (1977)
Cohen, A., Doyle, D., Martin, D., et al.: Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. New Engl. J. Med.295, 1449 (1976)
Stoop, J. W., Zegers, B. J.M., Hendrickx, G. F. M., et al.: Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. New Engl. J. Med.296, 651 (1977)
Virelizier, J., Hamet, M., Ballet, J., et al.: Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defect. J. Pediatr.92, 358 (1978)
Biggar, W. D., Giblett, E., Ozere, R., et al.: A new form of nucleoside phosphorylase deficiency in two brothers with defective T-cell function. J. Pediatr.92, 354 (1978)
Siegenbeek van Heukelom, L. H., Staal, G. E. J., Stoop, J. W., et al.: An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell and normal B-cell immunity. Clin. Chim. Acta.72, 117 (1976)
Fox, I. H., Andres, C. M., Gelfand, E., et al.: Purine nucleoside phosphorylase deficiency: Altered kinetic properties of a mutant enzyme. Science197, 1084 (1977)
Stoop, J. W., Eijsvoogel, V. P., Zegers, B., et al.: Selective severe cellular immunodeficiency — effect of thymus transplantation and transfer factor administration. Clin. Immunol. Immunopathol.6, 289 (1976)
Hong, R., Gatti, R., Rathbun, J. C., et al.: Thymic hypoplasia and thyroid dysfunction. New Engl. J. Med.282, 470 (1970)
Agarwal, R. P., Crabtree, G. W., Parks, R. E., Jr., et al.: Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immuno-deficiency. J. Clin. Invest.57, 1025 (1976)
Author information
Authors and Affiliations
Additional information
Supported in part by Clinical Studies Center Grant No. 2-MO-1-RR-00749-05
Rights and permissions
About this article
Cite this article
Meuwissen, H.J., Pollara, B. Combined immunodeficiency and inborn errors of purine metabolism. Blut 37, 173–181 (1978). https://doi.org/10.1007/BF00996718
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00996718